🎉 Up to 70% Off Selected ItemsShop Sale
HomeStore

Dobutamine Injection, USP 250 mg/20 ml Vial

Product image 1
Product image 2

Dobutamine Injection, USP 250 mg/20 ml Vial

Dobutamine Injection, USP 250 mg/20 ml Vial

Dobutamine Injection is a direct-acting inotropic agent primarily used to treat patients with heart disease or after heart surgery. It stimulates the heart's beta receptors, enhancing cardiac output with minimal effects on heart rate and peripheral vascular resistance. This medication is essential for managing low cardiac output states, such as acute heart failure and cardiogenic shock.

Key Features
  • Direct-acting inotropic agent
  • Stimulates beta receptors of the heart
  • Enhances cardiac output
  • Minimal increase in heart rate
Technical Specifications
  • Concentration 250 mg/20 ml
  • Form Injection Vial
  • Onset of Action 1-2 minutes
  • Duration of Action 10 minutes
  • Half-life 2 minutes
Application

Used in critical care units for inotropic support and afterload reduction in low cardiac output states.

Typical User/Industry Profile

Healthcare professionals in cardiology, emergency departments, and critical care units.

About the Brand

DBL is known for its high-quality pharmaceutical products, providing reliable solutions for critical care and emergency medicine.

$22.79
Dobutamine Injection, USP 250 mg/20 ml Vial—
$22.79

Product Information

Shipping & Returns

Description

Dobutamine Injection, USP 250 mg/20 ml Vial

Dobutamine Injection is a direct-acting inotropic agent primarily used to treat patients with heart disease or after heart surgery. It stimulates the heart's beta receptors, enhancing cardiac output with minimal effects on heart rate and peripheral vascular resistance. This medication is essential for managing low cardiac output states, such as acute heart failure and cardiogenic shock.

Key Features
  • Direct-acting inotropic agent
  • Stimulates beta receptors of the heart
  • Enhances cardiac output
  • Minimal increase in heart rate
Technical Specifications
  • Concentration 250 mg/20 ml
  • Form Injection Vial
  • Onset of Action 1-2 minutes
  • Duration of Action 10 minutes
  • Half-life 2 minutes
Application

Used in critical care units for inotropic support and afterload reduction in low cardiac output states.

Typical User/Industry Profile

Healthcare professionals in cardiology, emergency departments, and critical care units.

About the Brand

DBL is known for its high-quality pharmaceutical products, providing reliable solutions for critical care and emergency medicine.